日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CD47 stabilizes ROBO2 to regulate glioblastoma progression by preventing ITCH-mediated ubiquitination

CD47通过稳定ROBO2来调节胶质母细胞瘤的进展,其机制是通过阻止ITCH介导的泛素化。

Polara, Ruhi; Gliddon, Briony L; Ganesan, Raja; Davies, Lorena T; Toubia, John; Lenin, Sakthi; Siddiqui, Ghizal; Morris-Hanon, Olivia; Tea, Melinda N; Moretti, Paul A B; Nguyen, Dung A; Kok, Chung Hoow; Shard, Chloe; Staudacher, Alexander H; Brown, Michael P; Creek, Darren J; Gomez, Guillermo A; Thomas, Daniel; Pitson, Stuart M; Robinson, Nirmal

Shaping the future of multiple myeloma with artificial intelligence and digital twins: from concept to clinic

利用人工智能和数字孪生技术塑造多发性骨髓瘤的未来:从概念到临床

Lee, Cindy H; Zhang, Yang; McClure, Barbara J; Yong, Angelina; Scott, Hamish S; Kok, Chung Hoow

Comprehensive αβ T-Cell Receptor Repertoire Analysis Reveals a Unique CD8+ TCR Landscape in DOCK8-Deficient Patients

全面的αβ T细胞受体库分析揭示了DOCK8缺陷患者独特的CD8+ TCR图谱

Ceren Bozkurt,Gökhan Cildir,Umran Aba,Rahmi Kutay Erdogan,Nicholas I Warnock 1st,Chung Hoow Kok,Asena Pinar Sefer,Sule Haskologlu,Sidem Didar Tekeoglu,Gülşah Merve Kılınç,Canberk Ipsir,Tugba Arikoglu,Aylin Kont Ozhan,Saliha Esenboga,Ahmet Özen,Elif Karakoç-Aydiner,Sevgi Bilgiç Eltan,Çigdem Aydogmus,Candan Islamoglu,Kübra Baskın,Betul Karaatmaca,Ayse Metin,Deniz Çagdaş,Figen Dogu,Aydan Ikinciogullari,Safa Baris,Baran Erman

Validation of the 5th edition of the World Health Organization and International Consensus Classification guidelines for TP53-mutated myeloid neoplasm in an independent international cohort

在独立的国际队列中验证世界卫生组织和国际共识分类指南第五版中TP53突变型髓系肿瘤的分类标准

Shah, Mithun Vinod; Hung, Kevin; Baranwal, Anmol; Wechalekar, Gauri; Al-Kali, Aref; Toop, Carla R; Greipp, Patricia; Kutyna, Monika M; Matin, Aasiya; Ladon, Dariusz; Saliba, Antoine; Chen, Dong; Begna, Kebede; Brown, Anna; Rud, Danielle; Litzow, Mark R; Hogan, William J; Bardy, Peter; Badar, Talha; Kumar, Sharad; Yeung, David T; Patnaik, Mrinal M; Foran, James M; He, Rong; Gangat, Naseema; Hefazi, Mehrdad; Scott, Hamish S; Arana Yi, Cecilia Y; Alkhateeb, Hassan; Mangaonkar, Abhishek A; Thomas, Daniel; Hahn, Christopher N; Orazi, Attilio; Arber, Daniel A; Kok, Chung Hoow; Tefferi, Ayalew; Hiwase, Devendra

TRanscriptome ANalysis of StratifiEd CohorTs (TRANSECT) enables automated assessment of global gene regulation linked to disparate expression in user defined genes and gene sets

分层队列转录组分析 (TRANSECT) 能够自动评估与用户定义的基因和基因集的不同表达相关的全局基因调控。

Toubia, John; Kusay, Yasir; Maqsood, Muneeza; Warnock, Nicholas I; Lawrence, David M; Bracken, Cameron P; Gregory, Philip A; Kan, Winnie L; Selth, Luke A; Conn, Simon J; Lopez, Angel F; Branford, Susan; Scott, Hamish S; Kok, Chung Hoow; Goodall, Gregory J; Schreiber, Andreas W

IDH-mutant myeloid neoplasms are associated with seronegative rheumatoid arthritis and innate immune activation

IDH突变型髓系肿瘤与血清阴性类风湿性关节炎和先天免疫激活相关。

Hong, Lih En; Wechalekar, Mihir D; Kutyna, Monika; Small, Annabelle; Lim, Kelly; Thompson-Peach, Chloe; Li, Joule J; Chhetri, Rakchha; Scott, Hamish S; Brown, Anna; Hahn, Christopher N; Yeung, David T; Sajid, Salvia; Robinson, Nirmal; Thomas, Ranjeny; Branford, Susan; D'Andrea, Richard J; Samaraweera, Saumya E; Patnaik, Mrinal; Proudman, Susanna; Thomas, Daniel; Kok, Chung Hoow; Shah, Mithun V; Hiwase, Devendra K

Defective kinase activity of IKKα leads to combined immunodeficiency and disruption of immune tolerance in humans

IKKα激酶活性缺陷会导致人类联合免疫缺陷和免疫耐受性破坏。

Gökhan Cildir,Umran Aba,Damla Pehlivan,Denis Tvorogov,Nicholas I Warnock,Canberk Ipsir,Elif Arik,Chung Hoow Kok,Ceren Bozkurt,Sidem Tekeoglu,Gaye Inal,Mahmut Cesur,Ercan Kucukosmanoglu,Ibrahim Karahan,Berna Savas,Deniz Balci,Ayhan Yaman,Nazli Deveci Demirbaş,Ilhan Tezcan,Sule Haskologlu,Figen Dogu,Aydan Ikinciogulları,Ozlem Keskin,Damon J Tumes,Baran Erman

TP53 mutation variant allele frequency of ≥10% is associated with poor prognosis in therapy-related myeloid neoplasms

TP53突变变异等位基因频率≥10%与治疗相关性髓系肿瘤预后不良相关。

Shah, Mithun Vinod; Tran, Elizabeth Ngoc Hoa; Shah, Syed; Chhetri, Rakchha; Baranwal, Anmol; Ladon, Dariusz; Shultz, Carl; Al-Kali, Aref; Brown, Anna L; Chen, Dong; Scott, Hamish S; Greipp, Patricia; Thomas, Daniel; Alkhateeb, Hassan B; Singhal, Deepak; Gangat, Naseema; Kumar, Sharad; Patnaik, Mrinal M; Hahn, Christopher N; Kok, Chung Hoow; Tefferi, Ayalew; Hiwase, Devendra K

Impact of additional genetic abnormalities at diagnosis of chronic myeloid leukemia for first-line imatinib-treated patients receiving proactive treatment intervention

一线接受伊马替尼治疗并进行积极治疗干预的慢性粒细胞白血病患者,在诊断时发现的其他基因异常的影响

Shanmuganathan, Naranie; Wadham, Carol; Shahrin, NurHezrin; Feng, Jinghua; Thomson, Daniel; Wang, Paul; Saunders, Verity; Kok, Chung Hoow; King, Rob M; Kenyon, Rosalie R; Lin, Ming; Pagani, Ilaria S; Ross, David M; Yong, Agnes S M; Grigg, Andrew P; Mills, Anthony K; Schwarer, Anthony P; Braley, Jodi; Altamura, Haley; Yeung, David T; Scott, Hamish S; Schreiber, Andreas W; Hughes, Timothy P; Branford, Susan

Modelling ponatinib resistance in tyrosine kinase inhibitor-naïve and dasatinib resistant BCR-ABL1+ cell lines

在酪氨酸激酶抑制剂初治和达沙替尼耐药的 BCR-ABL1+ 细胞系中模拟普纳替尼耐药性

Liu Lu, Chung Hoow Kok, Verity Ann Saunders, Jueqiong Wang, Jennifer Anne McLean, Timothy Peter Hughes, Deborah Lee White